Monschein T, Dekany S, Zrzavy T, Ponleitner M, et al. Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR). J Neurol 2023 Jun 5. doi: 10.1007/s00415-023-11784.
PMID: 37272963